Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary
Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary
复制标题
DOI:
10.1159/000065067
复制
发表时间:
2002-01-01
期刊:
影响因子:
3.5
通讯作者:
Terakawa, N
中科院分区:
文献类型:
--
作者:
Itamochi, H;Kigawa, J;Terakawa, N
Resistance of clear cell carcinoma (CCC) of the ovary to platinum-based chemotherapy is associated with a poor prognosis. However, the mechanism underlying the resistance of CCC to platinum has not yet been understood. We conducted the present study to clarify the mechanism of cisplatin (CDDP) resistance in CCC cells. Eleven CCC and 5 serous adenocarcinoma (SAC) cell lines were used in this study. The IC50 to CDDP ranged from 1.3 to 18.0 muM for CCC cells and from 2.2 to 13.0 muM for SAC cells. There was no correlation between multidrug resistance-associated protein expression and the sensitivity to CDDP in CCC cells. In contrast, the doubling time for CCC cells was significantly longer than that for SAC cells (61.4 vs. 29.8 h). A significant reverse correlation between the S-phase fraction and the response to CDDP was observed (r = 0.647, p < 0.05). The present study suggests that the resistance of CCC to CDDP may be caused by low cell proliferation. Copyright (C) 2002 S. Karger AG, Basel.